Is It Still Safe To Buy Royal Bank of Scotland Group plc?

In this strong market, should you still buy Royal Bank of Scotland Group plc (LON: RBS)?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’m always searching for shares that can help ordinary investors like you make money from the stock market. However, many people are currently worried the market has been overheating.

So right now I’m analysing some of the most popular companies in the FTSE 100, hoping to establish if they can continue to outperform in today’s uncertain economy.

Today I’m looking at Royal Bank of Scotland (LSE: RBS) (NYSE: RBS.US) to determine whether the shares are still safe to buy at 301p.

So, how’s business going?

Over the past year or so, the market has been pleased with RBS’ performance as the company continues to rebuild itself. Indeed, the bank is in line to report a profit this year — its first since 2007.

However, City analysts have recently expressed concern that last month’s departure of turn-around chief Stephen Hester could slow the company’s final return to profitability.   

Furthermore, RBS’ management has revealed that the bank is becoming harder to run on a commercial and profitable basis as the UK government is increasingly intervening in the group’s operations, causing disagreements between the bank and its political partners.

That said, the bank’s day-to-day operations continue to perform well, and in May, RBS reported its first quarterly profit since 2011.

Moreover, the bank’s tier 1 capital ratio continues to improve and stood at 10.8% at the end of the first quarter, up from 10.3% at the end of 2012.

Expected growth

As I’ve said, RBS is expected to return to profit this year and many City analysts expect the bank’s earnings to grow rapidly next year as well. City forecasts currently predict earnings of 21.3p per share for this year (growth of 238%) and 31.5p for 2014.

Shareholder returns

Unlike some of its peers in the banking sector, RBS does not currently offer investors a dividend.

However, City analysts currently predict that the bank will begin to offer shareholders a token payout of 1.7p a share during 2014 to support an indicative dividend yield of 0.6%.


As RBS has not made a profit since 2007, it is not possible for me to calculate a historic P/E ratio for the company.

However, based on analyst estimates for future earnings, I believe the bank is currently trading at a forward P/E ratio of 14.2, cheaper than the company’s peers in the banking sector, which are currently trading at a historic P/E of 18.8.

Foolish summary

RBS is making a slow and steady return to health but the company is being hampered by government intervention and, after the upcoming departure of Stephen Hester, many investors are now anxious about the company’s future.

So overall, I feel that Royal Bank of Scotland does not look safe to buy at 301p.

More FTSE opportunities

Although I feel that it is not safe to buy Royal Bank of Scotland, I am more positive on the five FTSE shares highlighted within this exclusive wealth report.

Indeed, all five opportunities offer a mix of robust prospects, illustrious histories and dependable dividends, and have just been declared by the Fool as “5 Shares You Can Retire On“!

Just click here for the report — it’s free.

In the meantime, please stay tuned for my next FTSE 100 verdict

> Rupert does not own any share mentioned in this article.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

More on Investing Articles

Young Black man sat in front of laptop while wearing headphones
Investing Articles

Which of these is the best dirt cheap FTSE 100 stock to buy for 2024?

I'm building a list of the greatest FTSE 100 stocks to buy for the long term. But are these UK…

Read more »

Investing Articles

What’s on the cards for the BT share price in 2024?

After a turbulent few years, could the BT share price experience a better year ahead and how? This Fool investigates.

Read more »

Businesswoman analyses profitability of working company with digital virtual screen
Investing Articles

Lloyds shares could reach £1.50 in 2024

Lloyds shares rising from 43p to £1.50 in 2024 sounds like a tall order, but here is how the unloved…

Read more »

Long-term vs short-term investing concept on a staircase
Investing Articles

Should investors rush to buy Aviva shares before the end of the year?

The 7.5% dividend yield on Aviva shares is attractive. But Stephen Wright thinks a different FTSE 100 insurer is a…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

2 UK stocks for value investors to consider buying before the end of the year

Exploiting cyclical downturns can be a great way for value investors to find stocks to buy at bargain prices. Stephen…

Read more »

Young woman holding up three fingers
Investing Articles

I’d earn £1,260 in passive income by investing a £20k Isa in these 3 ultra-high-yield stocks

I'm on the hunt for passive income and I reckon the following FTSE 100 stocks should help me generate it…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

Could these beleaguered FTSE 100 stocks stage a turnaround?

Could these FTSE 100 stocks be primed for recovery after difficult times? Sumayya Mansoor takes a look at what could…

Read more »

Young black man looking at phone while on the London Overground
Investing Articles

Is this FTSE 100 giant one of the best income stocks out there?

Our writer takes a closer look at this medical business as a potential income stock for her portfolio, even though…

Read more »